000 01371 a2200397 4500
005 20250517231551.0
264 0 _c20190821
008 201908s 0 0 eng d
022 _a1865-8652
024 7 _a10.1007/s12325-018-0753-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTamási, Lilla
245 0 0 _aClinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler
_h[electronic resource]
260 _bAdvances in therapy
_cAug 2018
300 _a1140-1152 p.
_bdigital
500 _aPublication Type: Clinical Study; Journal Article; Multicenter Study
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBudesonide, Formoterol Fumarate Drug Combination
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMetered Dose Inhalers
650 0 4 _aMiddle Aged
650 0 4 _aPatient Reported Outcome Measures
650 0 4 _aPatient Satisfaction
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdrug therapy
650 0 4 _aQuality of Life
650 0 4 _aRespiratory Tract Absorption
650 0 4 _aTreatment Outcome
700 1 _aSzilasi, Maria
700 1 _aGálffy, Gabriella
773 0 _tAdvances in therapy
_gvol. 35
_gno. 8
_gp. 1140-1152
856 4 0 _uhttps://doi.org/10.1007/s12325-018-0753-6
_zAvailable from publisher's website
999 _c28689237
_d28689237